doctors may find new tests to simplify the MS diagnosis process. A blood test is being developed to detect biomarkers associated with MS. While this test likely won’t be able to diagnose MS on ...

Researchers at Australia's WEHI (Walter and Eliza Hall Institute) medical research center applied AI analysis to over 50,000 ...

Blood tests are often the first line of testing for evaluating MS symptoms. They can’t confirm a diagnosis of MS, but they can help rule out other conditions or point to a diagnosis. Multiple ...

today announced the discovery of new immune biomarkers in patients with non-active secondary progressive multiple sclerosis (na-SPMS) treated with nasal foralumab. We believe these findings ...

The following is a summary of “Neurofilament heavy chain in secondary progressive multiple sclerosis,” published in the January 2025 issue of Neurology by Angelis et al. Biomarkers are essential for ...

The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women.

reported the discovery of new immune biomarkers from its ongoing study of lead investigational product, intranasal Foralumab, in patients with non-active secondary progressive multiple sclerosis ...